Welcome to our dedicated page for HENRY SCHEIN SEC filings (Ticker: HSIC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Henry Schein, Inc. SEC filings document the formal disclosures of a Nasdaq-listed health care solutions company serving dental and medical practices and alternate care sites. The company’s 8-K filings report operating results, financial condition updates, press-release exhibits, leadership changes, board actions, and executive-compensation matters.
Proxy materials cover annual meeting matters, director and board-governance disclosures, and stockholder voting procedures. The filing record also identifies Henry Schein’s common stock, par value $0.01 per share, traded under HSIC on the Nasdaq Global Select Market, along with related corporate and Inline XBRL cover-page disclosures.
Henry Schein SVP & Chief Financial Officer Ronald N. South reported two stock dispositions on February 27, 2026. He disposed of 6,815 shares of common stock in a transaction coded as a disposition to the issuer and separately disposed of 709 shares at $82.39 per share to satisfy tax withholding obligations tied to the vesting of a March 1, 2023 performance-based restricted stock/unit grant. Following these transactions, he directly holds 73,850 shares of Henry Schein common stock.
Henry Schein Inc. senior vice president and chief human resources officer Christine Zayac Sheehy reported two share dispositions on common stock. She disposed of 780 shares to the company and a further 88 shares at $82.39 per share to satisfy tax withholding tied to the vesting of a March 1, 2023 performance-based restricted stock/unit grant. Following these transactions, she directly holds 11,830 shares of Henry Schein common stock.
Henry Schein Inc. executive Thomas C. Popeck, CEO of Henry Schein Products, reported dispositions of company stock on February 27, 2026. He disposed of a total of 1,339 shares, leaving him with 34,918 shares of common stock held directly after the transactions.
The filing shows an issuer disposition of 1,202 shares at a price of $0.00 per share. It also records a separate tax-withholding disposition of 137 shares at $82.39 per share. According to the footnote, those 137 shares were surrendered to Henry Schein to satisfy Popeck’s tax withholding obligation upon vesting of his March 1, 2023 grant of performance-based restricted stock/units, which vested on the preceding business day because March 1, 2026 was a non-business day.
Henry Schein Inc. executive Mark E. Mlotek reported share dispositions in company stock. On February 27, 2026, he disposed of 9,440 shares of common stock in a disposition to the issuer and a further 1,065 shares at $82.39 per share to cover tax withholding on vested performance-based restricted stock/units.
After these transactions, his direct holdings totaled 86,479 shares, which include shares held in joint tenancy with his spouse. He also reported indirect holdings of 5,916 equivalent shares as trustee of family trusts and 4,085 equivalent shares through a 401(k) plan stock fund.
Henry Schein’s EVP & Chief Operating Officer Michael S. Ettinger reported dispositions of company stock tied to equity award vesting, rather than open-market sales. On February 27, 2026, he disposed of 9,047 shares of common stock back to the issuer and an additional 914 shares at $82.39 per share to satisfy tax withholding obligations on his March 1, 2023 performance-based restricted stock/unit grant, according to the footnotes. After these transactions, he directly held 91,661 shares and had an indirect interest in the equivalent of 210 shares through the Henry Schein 401(k) Savings Plan’s unitized stock fund.
Henry Schein Inc. director and Chairman/CEO Stanley M. Bergman reported several stock transactions involving Henry Schein common shares. On March 2, 2026, entities associated with his spouse sold a total of 43,812 shares in open-market transactions at a weighted average price of about $81.31 per share. On February 27, 2026, he disposed of 48,531 shares directly back to the company and surrendered 7,349 shares to cover tax withholding upon vesting of a prior performance-based restricted stock/units grant, and he also reported 9,832 equivalent shares held through the company’s 401(k) plan.
Henry Schein executive Andrea Albertini reported share dispositions related to equity compensation. On February 27, 2026, he disposed of 3,999 shares of common stock back to the company and a further 440 shares at $82.39 per share as a tax-withholding disposition.
The footnote explains that the 440-share surrender covered tax withholding arising from the vesting of his March 1, 2023 grant of performance-based restricted stock/units. After these transactions, Albertini directly owned 61,461 shares of Henry Schein common stock.
Henry Schein insider sells shares under Form 144. The filing reports proposed and recent sales of common stock by Stanley M. Bergman and related trusts. The excerpt shows prior interfamily gifts of 19,954 and 23,858 shares and recent actual transactions of 38,346, 4,700, and 10,785 shares.
Henry Schein Inc. CEO and director Frederick M. Lowery filed an initial ownership report showing No Securities Beneficially Owned. The filing lists total direct holdings of 0 shares as of March 2, 2026, indicating no reportable equity position in the company at that time.
Henry Schein Inc. Chairman and CEO Stanley M. Bergman reported net open-market sales of 49,131 shares of common stock. The transactions included a direct sale of 10,785 shares at $81.20 per share and indirect sales totaling 38,346 shares at prices around $81 per share by entities associated with his spouse.
After these sales, Bergman directly owned 309,092 shares. Indirect holdings included 427,615 shares held through his spouse’s related trusts and entities, and 9,823 equivalent shares credited to his Henry Schein 401(k) Savings Plan account, calculated using the February 26, 2026 closing price.